Ruka hadi maudhui makuu

Condition · 1 treatment path

Pediatric Brain Tumour (Medulloblastoma)

Medulloblastoma is a fast-growing tumour of the cerebellum at the back of the brain, and it is the most common malignant brain tumour in children.

Severe
Request opinion View roster

Send your imaging + plan. Board-reviewed opinion in 5–10 working days.

Ilisasishwa mwisho: Jinsi tunavyokusanya na kukagua taarifa

Linear accelerator used for radiotherapy in a cancer treatment room
Treatment paths
1Treatment paths
Specialties
3Specialties
Typical severity
SevereTypical severity

About pediatric brain tumour (medulloblastoma)

What to know

Symptoms often come from raised pressure and blocked fluid flow, including morning headaches, vomiting, unsteady walking and clumsiness. Diagnosis is by MRI of the brain and spine, with surgery giving tissue for analysis and molecular grouping. Because it can spread through spinal fluid, staging includes a spinal MRI and fluid test.

Treatment starts with surgery to remove as much tumour as can be done safely, sometimes preceded by a shunt for fluid build-up. Radiotherapy to the brain and spine and chemotherapy follow in most children, with the dose depending on risk group and age. Rehabilitation supports recovery. Treatment abroad is often considered for proton beam therapy or specialist paediatric neuro-oncology.

Pre-flight workup

Tests to have already done

  • MRI of the whole brain and spine, with and without contrast, showing the tumour and any spread through the spinal fluid.
  • Post-operative MRI within about 48 to 72 hours, which shows the extent of tumour removed.
  • Pathology and molecular report classifying the subgroup (such as WNT, SHH, Group 3 or 4), which helps define risk.
  • Spinal fluid (CSF) cytology results, usually done about two weeks after surgery.
  • Details of any shunt or hydrocephalus treatment, hearing and kidney function tests, and endocrine baselines before chemotherapy and radiotherapy.

Second opinion

When to get a second look

  • The pathology has not been classified molecularly, and risk group is therefore unclear.
  • Your child is under about three to five years old and radiotherapy is proposed or avoided without a clear discussion of alternatives.
  • The tumour has recurred or progressed and a trial or new strategy is being considered.
  • Proton therapy, which can lower dose to healthy tissue, has not been discussed.

Talking to your doctor

Questions to ask

  1. What subgroup and risk category is my child's tumour?
  2. What proportion of the tumour was removed, and has it spread?
  3. What treatment plan do you recommend and what is the intent?
  4. What are the long-term effects on hearing, growth, thinking and hormones?
  5. What happens if it comes back?
  6. What follow-up scans and rehabilitation will be needed?

Outlook

Realistic prognosis

Outlook depends on risk group. In standard-risk disease in older children treated with surgery, radiotherapy and chemotherapy, a majority are long-term survivors. High-risk disease, metastases, certain molecular subtypes and very young age carry a poorer outlook. Survivors often have late effects on thinking, hearing, growth and hormones, so rehabilitation and long-term follow-up matter. The factors that change outcome are age, extent of surgery, spread, subgroup and the radiation approach.

01 · Specialties

Specialties that treat Pediatric

Specialists Doctors who treat pediatric brain tumour (medulloblastoma) Cross-hospital roster across 3+ relevant specialties. View roster

Diagnostic workup

Before you pick a hospital, get the workup right

Severe — workup typically within 48–72 hours

Picking the right treatment is downstream of a complete diagnosis. Skip steps here and the destination surgeon usually re-orders them anyway — at higher cost and another week on the ground.

  1. Confirm the diagnosis on imaging or labs

    For pediatric brain tumour (medulloblastoma), plan on the workup your home doctor would order anyway — typically a recent specialist consult plus the imaging / labs the destination team will need to quote accurately. Anything older than 90 days usually gets re-done.
  2. See a oncology specialist locally first

    An in-person clinical exam at home — even a single consult — costs little and dramatically improves the destination plan. Bring back: written impression, recommended procedure, surgical-risk class, and any contra-indications.
  3. Send us the file for a free second opinion

    Two surgeons in our medical panel review the workup independently. They tell you whether they'd operate, watch, or refer — even if that means recommending against travel.
  4. Pick a path with timeline + cost in writing

    Once a treatment is the right call, we line up 2–3 hospital options with itemized quotes, surgeon profiles, and a travel timeline. You hold the file — switch hospitals or step away at any point.

03 · Treatment paths

Treatment options

All treatments

Where to be treated

Pediatric Brain Tumour (Medulloblastoma) treatment by destination

Get a panel match

04 · FAQ

Common questions about pediatric brain tumour (medulloblastoma)

Is medulloblastoma curable?

Many children, particularly with standard-risk disease, are cured with combined treatment. Risk varies with age, spread and tumour biology.

Why is a biopsy alone not enough?

Surgery is both diagnostic and therapeutic here: removing as much tumour as safely possible matters, so a biopsy only is rarely the plan.

Will my child have learning problems?

Some do, especially after craniospinal radiation at a young age. Early rehabilitation and school support help.

Can proton therapy be used?

It may reduce radiation to healthy tissue and is considered in some centres. Ask your team.

Clinical context

Working up pediatric brain tumour (medulloblastoma) properly

A condition like pediatric brain tumour (medulloblastoma) is rarely well-served by jumping straight to treatment shopping. The sequence below is what a oncology specialist would expect to see completed — and the absence of any step is the right cue to delay travel decisions.

Diagnostic workup, in sequence

  1. First-line clinical assessment

    History, physical exam, and risk-factor review by a senior generalist or oncology specialist. Symptoms list, family history, prior workup notes, and current medication list should travel with the patient.

  2. Standard imaging + labs

    Baseline blood work, condition-specific imaging (ultrasound / X-ray / MRI / CT — depending on indication), and ECG / pulmonary function as relevant. Bring digital copies of any prior imaging — saves repeat scans and the cost that goes with them.

  3. Specialist diagnostic workup

    Procedure-specific tests — biopsy, cardiac catheterisation, endoscopy, or genetic / molecular profiling depending on the suspected diagnosis. Done at the centre that will treat, ideally, so results integrate cleanly into the treatment plan.

  4. Multidisciplinary review (where indicated)

    Cancer, complex cardiac, transplant, and rare-disease cases should be reviewed by a multidisciplinary panel — surgical, medical, imaging, and pathology — before any treatment commits. Single-discipline plans for complex disease are a quality red flag.

When to escalate urgently

  • Acute worsening of established symptoms — sudden chest pain, shortness of breath at rest, neurological deficit, severe bleeding, persistent high fever.
  • Loss of consciousness, severe persistent vomiting, or any focal neurological event.
  • Symptoms in the early hours of onset that fit a time-sensitive treatment window (stroke, MI, sepsis) — every hour costs outcome.
  • If you are travelling internationally for treatment and develop these symptoms in transit, divert to the nearest emergency department; do not wait to reach the planned destination.

Before you book international travel

  • Confirm your specific diagnosis is fully worked up before you commit to a treatment plan abroad. Travelling for the workup is fine; travelling for treatment without the workup done is not.
  • Get your case reviewed remotely by the destination centre's team before you book flights — credible international patient programs review imaging + reports before they confirm the surgical plan.
  • Bring a digital + physical copy of your full medical record: imaging on USB drive in DICOM format, labs in PDF, current medication list with dosages, allergies, and any prior surgical reports.
  • Plan for longer recovery + post-discharge therapy continuation before you fly — the surgery itself is rarely the bottleneck.
  • Confirm that follow-up imaging and any necessary in-person reviews can be done at home — a treatment plan that requires repeat international trips is more burdensome (and more expensive) than the headline procedure.
Jinsi ukurasa huu ulivyoandaliwa

Mbinu na viwango vya uhariri

This pediatric brain tumour (medulloblastoma) overview is written by the editorial team from published Oncology sources and lists 1 treatment options offered by hospitals on our network. The page shows its last-updated date. Clinical descriptions are editorial — your treating clinician confirms what's right for your specific case.

  1. Taarifa za hospitali. Maelezo ya hospitali yanakusanywa kutoka vyanzo vya umma na tovuti za hospitali. Uidhinishaji (JCI, NABH na mengine) huonyeshwa pale tulipo na rekodi. Daima omba hospitali cheti chake cha sasa.
  2. Sifa za madaktari. Sifa, utaalamu na wasifu hutoka wasifu wa daktari hospitalini. Leseni hukaguliwa kwenye rejista ya baraza la kitaifa la madaktari tu pale wasifu unapoonyesha alama ya "Leseni imehakikiwa" yenye tarehe.
  3. Bei. Viwango vya bei ni vya kukadiria, vimekusanywa kutoka orodha za bei na vifurushi vya hospitali na huonyeshwa na tarehe ya mwisho ya kusasishwa. Unacholipa ni kile kilichoandikwa kwenye nukuu ya hospitali.
  4. Maandishi ya kitabibu. Imeandikwa na timu ya wahariri ya Medcasts kutoka vyanzo vya kliniki vilivyochapishwa. Isipokuwa ukurasa umetaja mhakiki kwa jina, haujakaguliwa na daktari.
  5. Uhuru. Hospitali haziwezi kulipa ili kubadilisha nafasi yao kwenye kurasa zetu.
Vyanzo vya taarifa za ukurasa huu
Peer-reviewed clinical guidelines (NCCN, ESMO, ESC, AHA, NICE — by indication)WHO ICD-11 condition classificationNational medical society treatment protocolsJCI accreditation registry

Pediatric Brain Tumour (Medulloblastoma)

Continue evaluating pediatric brain tumour (medulloblastoma) care

Condition overview is one entry. These hubs route the same care decision via specialty, surgeon, treatment, and destination — including the doctors actively treating pediatric brain tumour (medulloblastoma).

Hatua inayofuata · Pediatric Brain Tumour (Medulloblastoma)

Free second opinion on your Pediatric case.

Share imaging and the current plan. Multidisciplinary board returns a written opinion within 5–10 working days — no obligation to travel.

Pata makadirio ya bei bureMakadirio ya kina kutoka hospitali zilizoidhinishwa, bila malipo Maoni ya pili ya daktari bureMtaalamu anapitia ripoti zako Ongea na mratibuWhatsApp, barua pepe au simu